Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M99,854Revenue (TTM) $M37,719Net Margin (%)12.3Altman Z-Score1.9
Enterprise Value $M113,051EPS (TTM) $1.8Operating Margin %14.6Piotroski F-Score7
P/E(ttm)21.5Beneish M-Score-2.7Pre-tax Margin (%)13.5Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %-4.5Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow16.6y-y EBITDA Growth Rate %-3.8ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %4.3PEG--ROE % (ttm)7.5Less Shares Outstanding y-yY
Payout Ratio %92.0Shares Outstanding M2,574ROIC % (ttm)6.7Gross Margin Increase y-yY

Gurus Latest Trades with SNY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYNWQ Managers 2016-06-30 Sold Out -1.22%$38.13 - $44.32
($40.99)
$ 38.79-5%Sold Out0
SNYDavid Dreman 2016-06-30 Add0.47%$38.13 - $44.32
($40.99)
$ 38.79-5%Add 980.43%20,204
SNYHOTCHKIS & WILEY 2016-06-30 Add0.23%$38.13 - $44.32
($40.99)
$ 38.79-5%Add 12.47%11,432,112
SNYJohn Paulson 2016-06-30 Buy 0.17%$38.13 - $44.32
($40.99)
$ 38.79-5%New holding395,500
SNYDodge & Cox 2016-06-30 Add0.07%$38.13 - $44.32
($40.99)
$ 38.79-5%Add 3.04%55,155,913
SNYBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.06%$38.13 - $44.32
($40.99)
$ 38.79-5%Reduce -3.32%28,122,279
SNYCharles Brandes 2016-06-30 Add0.03%$38.13 - $44.32
($40.99)
$ 38.79-5%Add 1.24%3,600,731
SNYKen Fisher 2016-06-30 Add0.01%$38.13 - $44.32
($40.99)
$ 38.79-5%Add 0.67%13,638,183
SNYJoel Greenblatt 2016-06-30 Add$38.13 - $44.32
($40.99)
$ 38.79-5%Add 2.45%35,571
SNYCharles Brandes 2016-03-31 Add0.78%$38.37 - $42.65
($40.17)
$ 38.79-3%Add 61.76%3,556,721
SNYDodge & Cox 2016-03-31 Add0.14%$38.37 - $42.65
($40.17)
$ 38.79-3%Add 7.24%53,530,129
SNYNWQ Managers 2016-03-31 Reduce-0.09%$38.37 - $42.65
($40.17)
$ 38.79-3%Reduce -6.34%1,946,427
SNYBill Nygren 2016-03-31 Reduce-0.05%$38.37 - $42.65
($40.17)
$ 38.79-3%Reduce -3.53%5,470,000
SNYBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.03%$38.37 - $42.65
($40.17)
$ 38.79-3%Reduce -1.36%29,087,790
SNYJoel Greenblatt 2016-03-31 Buy 0.02%$38.37 - $42.65
($40.17)
$ 38.79-3%New holding34,720
SNYDavid Dreman 2016-03-31 Buy 0.01%$38.37 - $42.65
($40.17)
$ 38.79-3%New holding1,870
SNYKen Fisher 2016-03-31 Add0.01%$38.37 - $42.65
($40.17)
$ 38.79-3%Add 0.97%13,546,950
SNYMario Gabelli 2016-03-31 Sold Out $38.37 - $42.65
($40.17)
$ 38.79-3%Sold Out0
SNYHOTCHKIS & WILEY 2016-03-31 Add$38.37 - $42.65
($40.17)
$ 38.79-3%Add 0.23%10,164,994
SNYNWQ Managers 2015-12-31 Reduce-0.31%$41.51 - $51.49
($45.91)
$ 38.79-16%Reduce -16.94%2,078,119
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-59.29view
Sanofi10% Owner 2015-01-26Buy647,448$95-59.29view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-58.5view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-42.18view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67404.17view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Why Berkshire Hathaway Dumped Johnson & Johnson Jul 19 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies Jun 13 2016 
    Endonovo Therapeutics: Innovative Treatment, Catalyst Create Compelling Opportunity May 22 2016 
    Charles Brandes Trims Stake in South American Petroleum Company May 13 2016 
    Warren Buffett’s Top 5 Dividend Yielding Stocks Apr 26 2016 
    Manning & Napier Sells Chunks of Stakes in GE, Eli Lilly, Merck Mar 29 2016 
    Amgen: Should I Just Sit and Wait? Mar 18 2016 
    Sanofi's New Products Will Fuel Sales Mar 13 2016 
    Warren Buffett's Worst Performing Stocks Mar 03 2016 

    More From Other Websites
    Week In Review: 'Strengthened' Yellen, Mylan EpiPen Furor, Best Buy Hot, Dollar Stores Pinched Aug 26 2016
    What Do Analysts Think about BioMarin’s Return Potential? Aug 26 2016
    ETF’s with exposure to Sanofi : August 26, 2016 Aug 26 2016
    Sanofi Just Can’t Catch a Break, Knocking at Major Support Again Aug 26 2016
    How Mylan's EpiPen Fight Could Sting Investors Aug 25 2016
    Sanofi :SNY-US: Earnings Analysis: Q1, 2016 By the Numbers : August 25, 2016 Aug 25 2016
    Medivation: The Latest Analyst Recommendations Aug 24 2016
    10 Stocks Billionaire John Paulson Is Buying for 2016 Aug 24 2016
    4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss Aug 23 2016
    3 Best Dividend Stocks Owned by Warren Buffett Aug 23 2016
    This Changed Sanofi’s Profitability in 2Q16 Aug 23 2016
    Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised) Aug 23 2016
    The $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation Aug 22 2016
    In possible $14 billion ending, Medivation goes back to early days Aug 22 2016
    Pfizer boosts cancer drug roster with $14 billion Medivation deal Aug 22 2016
    Pfizer boosts cancer drug roster with $14 billion Medivation deal Aug 22 2016
    Pfizer-Medivation Deal Reignites Biotech Buyout Speculation Aug 22 2016
    Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised) Aug 22 2016
    Betting on BioMarin Aug 22 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)